Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Xiaofen Li1 Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, [email protected]; [email protected];2 Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Xia Li3 Department of Operation Room, Zhejiang Province People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China

Xuefeng Fang1 Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Ying Yuan1 Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date